A detailed history of Gam Holding Ag transactions in Inhibrx, Inc. stock. As of the latest transaction made, Gam Holding Ag holds 8,000 shares of INBX stock, worth $113,360. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,000
Holding current value
$113,360
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$32.76 - $39.56 $262,079 - $316,480
8,000 New
8,000 $279,000

Others Institutions Holding INBX

About Inhibrx, Inc.


  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $553M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.